Delivery Order SPE2DB20D1100-SPE2DB24FD6F8

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,720.79 firm fixed-price delivery order contract is for the supply of Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of November 14, 2023 and was awarded on November 13, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,517.18 firm fixed-price delivery order is for the supply of 4,566,249,434 units of ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,848.37 firm fixed-price delivery order is for the supply of 4562301229 - Ondansetron ODT 8 mg Tablet 30s, with a completion date of September 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ondansetron ODT 8 mg tablets. The $11,254.23 fixed-price Delivery Order contract has a completion date of May 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,936.49 fixed-price delivery order is for the supply of 4,566,188,150 units of Ondansetron ODT 8 mg tablets, with a completion date of October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,172.28 firm fixed-price delivery order is for the supply of 4566832375 - Ondansetron ODT 8 mg Tablets in 30-count packages. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,902.39 Firm Fixed Price Delivery Order is for the supply of 4 mg Ondansetron ODT (Orally Disintegrating Tablet) in 30-count packages. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order valued at $2,154.60 for the supply of Ondansetron ODT 8 mg tablets. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 11, 2025 and is a Firm Fixed Price agreement. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,739.22 firm fixed price delivery order is for the supply of Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of September 20, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,098.88 firm fixed-price delivery order is for the supply of Ondansetron ODT 8 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD6F8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,659.21 firm-fixed-price delivery order is for the supply of Ondansetron ODT 8 mg tablets. As the award was not set aside, it was competed on an unrestricted basis. The contract has an ultimate completion date of September 5, 2024.

AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to hundreds of millions of dollars, to provide a wide range of pharmaceutical and medical products to support military treatment facilities, veterans' hospitals, and other government healthcare programs. This specific delivery order is likely part of one of these larger IDCs, enabling the government to efficiently procure essential medications from a trusted supplier.

Generated 12/4/24, 9:02 AM